Daily Stock Analysis, EKSO, Ekso Bionics Holdings Inc, priceseries

Ekso Bionics Holdings Inc. Daily Stock Analysis
Stock Information
Open
1.28
Close
1.26
High
1.31
Low
1.25
Previous Close
1.28
Daily Price Gain
-0.02
YTD High
2.55
YTD High Date
Apr 11, 2019
YTD Low
1.18
YTD Low Date
May 22, 2019
YTD Price Change
-0.16
YTD Gain
-11.27%
52 Week High
3.30
52 Week High Date
Aug 15, 2018
52 Week Low
1.18
52 Week Low Date
May 22, 2019
52 Week Price Change
-0.50
52 Week Gain
-28.37%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 17. 2017
3.26
Apr 3. 2017
3.53
11 Trading Days
8.14%
Link
LONG
Jun 12. 2017
1.26
Jul 5. 2017
2.07
16 Trading Days
63.99%
Link
LONG
Nov 10. 2017
1.53
Nov 29. 2017
2.54
12 Trading Days
66.03%
Link
LONG
Jan 2. 2019
1.42
Jan 28. 2019
1.66
17 Trading Days
16.77%
Link
Company Information
Stock Symbol
EKSO
Exchange
NasdaqCM
Company URL
http://www.eksobionics.com
Company Phone
510-984-1761
CEO
Thomas Looby
Headquarters
California
Business Address
1414 HARBOUR WAY SOUTH, SUITE 1201, RICHMOND, CA 94804
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001549084
About

Ekso Bionics Holdings, Inc. designs, develops and sells wearable bionic human exoskeletons that have applications in healthcare, industrial, military, and consumer markets. The company operates through Engineering Services and Medical business segments. The Engineering services segment engages in research and development service arrangements, technology license agreements, and government grants. The Medical service segment designs, engineers, and manufactures exoskeletons for applications in the medical and military markets. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.

Description

Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, military, and consumer markets in North America, Europe, the Middle East, and Africa. The company operates through Medical Devices, Industrial Sales, and Engineering Services segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries, hemiplegia due to stroke, and lower limb paralysis or weakness. The company's Ekso device is primarily used in a clinic or rehabilitation setting. It also performs research and development work on human exoskeletons and related technologies. The company has a license agreement with Lockheed Martin Corporation to develop products for military applications, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California. Ekso Bionics Holdings, Inc. operates as a subsidiary of Magee Rehabilitation Hospital.